How Is IDC Diagnosed Following an Abnormal Mammogram?

Being called back after an abnormal screening mammogram is a common and anxiety-inducing experience. It is important to know that an abnormal mammogram does not definitively mean you have invasive ductal carcinoma (IDC) or any type of breast cancer. An abnormal screening scan simply means that the radiologist saw something that requires a closer look. A definitive cancer diagnosis can only be made after a sample of tissue is removed and examined under a microscope ^[1].

The process of confirming or ruling out a diagnosis of IDC involves a step-by-step diagnostic workup.

Step 1: Diagnostic Imaging

The first step after a callback is to gather more detailed images of the specific area of concern.

• Diagnostic Mammography: Unlike a standard screening mammogram, a diagnostic mammogram focuses on the exact spot that looked suspicious. It uses specialized angles and additional views to help the radiologist characterize the area more clearly ^[2].
• Targeted Ultrasound: After or alongside the diagnostic mammogram, a targeted ultrasound is often performed on the specific area. Ultrasound uses sound waves to create images and is particularly good at determining if a lump is a solid mass or a harmless, fluid-filled cyst ^[2].

Once these images are reviewed, the radiologist assigns a BI-RADS category (Breast Imaging Reporting and Data System), which ranges from 0 to 6.

• Category 0: Needs additional imaging (this is often the reason for an initial callback) ^[3].
• Categories 1 and 2: Normal or benign (non-cancerous) findings.
• Category 3: Probably benign; usually requires short-interval follow-up imaging rather than an immediate biopsy ^[4].
• Categories 4 and 5: Suspicious or highly suspicious; this usually leads to a recommendation for a biopsy ^[5].
• Category 6: Known, biopsy-proven malignancy.

Step 2: Core-Needle Biopsy

If your imaging falls into category 4 or 5, a tissue sample is required. A core-needle biopsy is the most common method used.

What to expect during the biopsy: You will be given a local anesthetic to numb the area. During the procedure, you may feel pressure or hear a clicking sound as the doctor uses a hollow needle to remove small cylinders (cores) of tissue. A tiny, safe metal marker clip is often left in the breast to mark the exact spot for future reference. Afterward, it is normal to experience some bruising and soreness; your clinic will provide instructions on managing this and when to call if you experience severe pain or signs of infection.

Because the doctor needs to be precise, they will use imaging to guide the needle:

• Ultrasound-guided biopsy is typically used when the abnormality can be clearly seen on an ultrasound ^[6].
• Stereotactic biopsy uses mammography images from different angles to guide the needle. This is commonly used for tiny calcium deposits (calcifications) that aren’t visible on an ultrasound ^[7].
• MRI-guided biopsy may be used if the abnormality is only visible on a breast MRI ^[7].

Step 3: Pathology and Biomarker Testing

The tissue samples are sent to a laboratory, where a specialized doctor called a pathologist examines them under a microscope.

To diagnose invasive ductal carcinoma, the pathologist looks at the overall appearance (architecture) of the cells. Invasive simply means that abnormal cells have broken through the wall of the milk duct and grown into the nearby breast tissue (the stroma) ^[8]. It does not automatically mean the cancer has spread to lymph nodes or other organs. Pathologists sometimes use special stains to help them distinguish invasive cancer from contained (in situ) disease, but they rely on the overall microscopic picture rather than a single stain to make the diagnosis ^[9].

If IDC is confirmed, the pathologist runs additional biomarker tests to help plan your treatment:

• Tumor Grade: An estimate of how abnormal the cells look and how aggressively they may behave, based on their microscopic features ^[10].
• Hormone Receptor Status (ER and PR): Tests whether the cancer cells have receptors for estrogen or progesterone. This helps predict if the cancer will respond to hormone-blocking (endocrine) therapies ^[11].
• HER2 Status: Tests for a protein that can drive tumor growth. A positive result means the cancer may respond well to HER2-targeted treatments. If the initial test result is borderline (an IHC score of 2+), a second test—such as FISH (fluorescence in situ hybridization)—is used to clarify it ^[12].

What If the Biopsy is Benign?

A benign (non-cancerous) biopsy result is a relief, but the radiologist must confirm that it makes sense given the initial abnormal scan. This is called radiologic-pathologic concordance. If the benign biopsy result adequately explains what was seen on the mammogram, you may just need routine follow-up. However, if the benign result is “discordant”—meaning it doesn’t explain a highly suspicious scan—your doctor will likely recommend a repeat biopsy or surgical excision to be absolutely sure no cancer was missed ^[13].

When Is a Breast MRI Used?

Breast MRI is a highly sensitive imaging tool, but it is not a routine requirement for everyone newly diagnosed with IDC ^[14]. Your doctor might recommend an MRI in specific situations, such as if your initial scans are unclear, if you have very dense breasts, or if the surgeon needs help planning your operation.

However, MRI can sometimes find additional harmless areas that look suspicious (false positives). This can lead to extra biopsies and anxiety without necessarily improving your treatment plan ^[15]. Therefore, the decision to use MRI is highly individualized.

How Long Does the Diagnostic Process Take?

Waiting for appointments and results is often the most stressful part of this process. Timelines vary widely depending on your local clinic’s capacity. Based on studies of various healthcare systems, the timeline might look like this:

• Callback to Diagnostic Imaging: Some clinics offer same-day or next-day appointments, while in some studies, the median wait was 9 to 14 days ^[16].
• Diagnostic Imaging to Biopsy: This can take another 1 to 3 weeks (averages range from 6 to 21 days in research studies) ^[17][16].
• Biopsy to Pathology Results: Once the biopsy is done, pathology and biomarker results typically take a few days to a week to be finalized.

While a rapid process is ideal, it is not uncommon for the entire diagnostic timeline to take a few weeks ^[18]. If you are concerned about delays or haven’t received your results when expected, it is always okay to ask your care team if there are options for a sooner appointment or to be placed on a cancellation list.